• Skip to primary navigation
  • Skip to main content
SRI logo
  • About
    • Press room
    • Our history
  • Expertise
    • Advanced imaging systems
    • Artificial intelligence
    • Biomedical R&D services
    • Biomedical sciences
    • Computer vision
    • Cyber & formal methods
    • Education and learning
    • Innovation strategy and policy
    • National security
    • Ocean & space
    • Quantum
    • Robotics, sensors & devices
    • Speech & natural language
    • Video test & measurement
  • Ventures
  • NSIC
  • Careers
  • Contact
  • 日本支社
Search
Close
Bios September 8, 2021

Parijat Bhatnagar

Program Director, Cell-based Medicine; Center for Chemical Biology

Parijat Bhatnagar, Ph.D., is the Program Director for Cell-based Medicine at SRI International. He is a recipient of multiple grant awards including NIH Director’s New Innovator Award and DARPA Young Faculty Award. The focus of his research program is to engineer mammalian cells into platform therapeutics and diagnostics. The engineered cells actively seek disease microenvironments, assess the disease burden, and synthesize proportionate amounts of therapeutic drugs. To accomplish this goal, his team uses synthetic biology and engineering principles to transform cells for responding to different stimuli and bioreactors for clinical-scale manufacturing. With a vision to translate this technology through phased preclinical and clinical trials, he is pursuing his research in the Biosciences Division at SRI International.

Bhatnagar’s multidisciplinary interests derive from his career trajectory that spans across semiconductor manufacturing, industrial engineering, and biotechnology within the context of immune cell engineering, materials design, surface chemistry, and instrumentation.

Bhatnagar has a PhD in biomedical engineering from Cornell University, Ithaca, NY and completed a joint postdoctoral training program in imaging of adoptively transferred cells from at MD Anderson Cancer Center and at Houston Methodist Research Institute.

Join the laboratory for Cell-based Medicine

Positions at all levels (BS/MS/PhD) are generally available. We welcome applications from self-starting enthusiastic candidates who may be interested in exploring the next frontier in T-cell engineering. Interested candidates from immunology and engineering or related backgrounds are encouraged to contact Dr. Bhatnagar at https://www.linkedin.com/in/parijatbhatnagar

Links

  • SRI’s Parijat Bhatnagar receives DARPA award to continue groundbreaking research into engineered immunity
  • SRI International’s Parijat Bhatnagar Wins Prestigious NIH New Innovator Award
  • T-cell biofactories find, fight disease in one fell swoop
  • SRI International’s Parijat Bhatnagar Wins Prestigious DARPA Young Faculty Award
  • List of Publications and Patents

Recent publications

more +
  • Genetically engineered pair of cells for serological testing and its application for SARS-CoV-2

    We have developed a serology test platform for identifying individuals with prior exposure to specific viral infections and provide data to help reduce public health risks.

  • Electrically regulated cell-based intervention for viral infections 

    This work reports on an engineered cell that—when electrically stimulated—synthesizes a desired protein, that is, ES-Biofactory.

  • Cell-Based Platform for Antigen Testing and Its Application for SARS-CoV-2 Infection 

    We have engineered a cell that can be used for diagnosing active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

  • Antiviral T-cell Biofactory platform for SARS-CoV-2 

    We engineered a T cell to synthesize interferons (IFNs) as antiviral proteins upon recognizing the virus envelop protein of SARS-CoV-2, i.e., anti-SARS T-cell Biofactory.

  • NK-Cell Biofactory as an Off-the-Shelf Cell-based Vector for Targeted In Situ Synthesis of Engineered Proteins

    NK-cell Biofactory is an off-the-shelf allogeneic platform for cell-based synthesis of desired protein following recognition of a target cell while conserving the cytolytic activity.

  • Lentivirus Manufacturing Process for Primary T‐Cell Biofactory Production

    A process for maximizing the titer of lentivirus particles, deemed to be a necessity for transducing primary cells, is developed.

Career call to action image

Work with us

Search jobs

How can we help?

Once you hit send…

We’ll match your inquiry to the person who can best help you.

Expect a response within 48 hours.

Our work

Case studies

Publications

Timeline of innovation

Areas of expertise

Institute

Leadership

Press room

Media inquiries

Compliance

Careers

Job listings

Contact

SRI Ventures

Our locations

Headquarters

333 Ravenswood Ave
Menlo Park, CA 94025 USA

+1 (650) 859-2000

Subscribe to our newsletter


日本支社
SRI International
  • Contact us
  • Privacy Policy
  • Cookies
  • DMCA
  • Copyright © 2023 SRI International
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}